We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CLP (CLP) | CLP (CLP) | CLP (CLP) | CLP (CLP) | CLP (CLP) | CLP (CLP) | CLP (CLP) | CLP (CLP) | |
Return on Assets (%) | 2.034 | 2.105 | 2.092 | 1.848 | 1.278 | 1.879 | 3.05 | 2.72 |
Return on Equity (%) | 22.21 | 22.251 | 22.741 | 21.617 | 15.809 | 23.004 | 34.687 | 28.975 |
Operating Leverage | -0.023 | 0.036 | 0.008 | -0.031 | -0.084 | 0.246 | 0.327 | -0.139 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 97.62B | 97.62B | 101.02B | 101.02B | 101.02B | 101.02B | 101.02B | 101.02B |
Year End December 30 2023 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|---|---|---|
CLP (CLP) | CLP (CLP) | CLP (CLP) | CLP (CLP) | CLP (CLP) | CLP (CLP) | CLP (CLP) | CLP (CLP) | |
Shares Outstanding | 101.02B | 101.02B | 101.02B | 101.02B | 101.02B | 101.02B | 101.02B | 101.02B |
Return on Assets (%) | N/A | N/A | 0.703 | N/A | N/A | N/A | 0.607 | N/A |
Return on Equity (%) | N/A | N/A | 8.366 | N/A | N/A | N/A | 7.093 | N/A |
Operating Leverage | N/A | N/A | 0.009 | N/A | N/A | N/A | -0.063 | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 101.02B | 101.02B | 101.02B | 101.02B | 101.02B | 101.02B | 101.02B | 101.02B |
Market Cap | 11.84B |
Price to Earnings Ratio | 0.01 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 505.09M |
Average Volume (1 week) | 199.05k |
Average Volume (1 Month) | 156.47k |
52 Week Change | 6.88% |
52 Week High | 24.79 |
52 Week Low | 19.20 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions